Twist Bioscience

Twist Bioscience Corporation is a synthetic biology company that manufactures synthetic DNA at scale on a proprietary silicon-based synthesis platform. Its product lines include synthetic genes, oligo pools, variant libraries, antibody discovery libraries, next-generation sequencing target enrichment panels and biopharma drug-discovery services, sold into healthcare, industrial chemicals, agriculture and academic research markets. The company was founded in 2013 and is headquartered in South San Francisco, California. Its discovery-data offering supplies machine-learning-ready small-molecule and antibody developability data to pharmaceutical partners, including an October 2026 agreement with Eli Lilly's TuneLab network.